BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28288747)

  • 1. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial.
    Gibson DG; Ochieng B; Kagucia EW; Were J; Hayford K; Moulton LH; Levine OS; Odhiambo F; O'Brien KL; Feikin DR
    Lancet Glob Health; 2017 Apr; 5(4):e428-e438. PubMed ID: 28288747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya.
    Wakadha H; Chandir S; Were EV; Rubin A; Obor D; Levine OS; Gibson DG; Odhiambo F; Laserson KF; Feikin DR
    Vaccine; 2013 Jan; 31(6):987-93. PubMed ID: 23246258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mobile Solutions for Immunization (M-SIMU) Trial: A Protocol for a Cluster Randomized Controlled Trial That Assesses the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya.
    Gibson DG; Kagucia EW; Ochieng B; Hariharan N; Obor D; Moulton LH; Winch PJ; Levine OS; Odhiambo F; O'Brien KL; Feikin DR
    JMIR Res Protoc; 2016 May; 5(2):e72. PubMed ID: 27189422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mobile phone delivered reminders and unconditional incentives on measles-containing vaccine timeliness and coverage: a randomised controlled trial in western Kenya.
    Kagucia EW; Ochieng B; Were J; Hayford K; Obor D; O'Brien KL; Gibson DG
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33509838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Text Message Reminders and Unconditional Monetary Incentives to Improve Measles Vaccination in Western Kenya: Study Protocol for the Mobile and Scalable Innovations for Measles Immunization Randomized Controlled Trial.
    Gibson DG; Kagucia EW; Were J; Obor D; Hayford K; Ochieng B
    JMIR Res Protoc; 2019 Jul; 8(7):e13221. PubMed ID: 31290405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mobile phone text message reminders on improving completeness and timeliness of routine childhood vaccinations in North-West, Ethiopia: a study protocol for randomised controlled trial.
    Mekonnen ZA; Tilahun B; Alemu K; Were M
    BMJ Open; 2019 Nov; 9(11):e031254. PubMed ID: 31694849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMS reminders to improve the uptake and timeliness of the primary immunisation series in infants: a multi-centre randomised controlled trial.
    O'Grady KF; Kaus M; Jones L; Boddy G; Rablin S; Roberts J; Arnold D; Parfitt S; Johnston R; Hall KK; Le Gros-Wilson S; Butten K; Toombs M; Lambert SB
    Commun Dis Intell (2018); 2022 May; 46():. PubMed ID: 35591748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana.
    Levine G; Salifu A; Mohammed I; Fink G
    PLoS One; 2021; 16(5):e0247485. PubMed ID: 34010312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do mobile phone-based reminders and conditional financial transfers improve the timeliness of childhood vaccinations in Tanzania? Study protocol for a quasi-randomized controlled trial.
    Ostermann J; Vasudevan L; Baumgartner JN; Ngadaya E; Mfinanga SG
    Trials; 2019 Jul; 20(1):397. PubMed ID: 31272487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Black AP; Muller CP
    PLoS One; 2020; 15(12):e0242502. PubMed ID: 33290386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Mobile Phone Text Message Reminders on Routine Immunization Uptake in Pakistan: Randomized Controlled Trial.
    Kazi AM; Ali M; Zubair K; Kalimuddin H; Kazi AN; Iqbal SP; Collet JP; Ali SA
    JMIR Public Health Surveill; 2018 Mar; 4(1):e20. PubMed ID: 29514773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
    Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.
    Ndiritu M; Cowgill KD; Ismail A; Chiphatsi S; Kamau T; Fegan G; Feikin DR; Newton CR; Scott JA
    BMC Public Health; 2006 May; 6():132. PubMed ID: 16707013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating a Mobile Phone-Delivered Text Message Reminder Intervention to Reduce Infant Vaccination Dropout in Arua, Uganda: Protocol for a Randomized Controlled Trial.
    Ehlman DC; Magoola J; Tanifum P; Wallace AS; Behumbiize P; Mayanja R; Luzze H; Yukich J; Daniels D; Mugenyi K; Baryarama F; Ayebazibwe N; Conklin L
    JMIR Res Protoc; 2021 Feb; 10(2):e17262. PubMed ID: 33625372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.
    Dodoo AN; Renner L; van Grootheest AC; Labadie J; Antwi-Agyei KO; Hayibor S; Addison J; Pappoe V; Appiah-Danquah A
    Drug Saf; 2007; 30(4):347-56. PubMed ID: 17408311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2012 Apr; (4):CD005530. PubMed ID: 22513932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.
    Nolan T; Hogg G; Darcy MA; Skeljo M; Carlin J; Boslego J
    Vaccine; 2001 Feb; 19(15-16):2127-37. PubMed ID: 11228385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.